NCT00541502View on ClinicalTrials.gov

Improving Cognitive Function of Aripiprazole in Treating Adolescents and Young Adults With Psychotic Disorder

UnknownOBSERVATIONAL
Timeline

Start Date

November 30, 2007

Study Completion Date

October 31, 2008

Conditions
Psychotic Disorders
Sponsors
All Listed Sponsors
collaborator

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

lead

Genovate Biotechnology Co., Ltd.,

INDUSTRY

NCT00541502 - Improving Cognitive Function of Aripiprazole in Treating Adolescents and Young Adults With Psychotic Disorder | Biotech Hunter | Biotech Hunter